416 results on '"Moelans, Cathy B"'
Search Results
52. Absence of chromosome 17 polysomy in breast cancer: analysis by CEP17 chromogenic in situ hybridization and multiplex ligation-dependent probe amplification
53. CEP17 copy number increase does not indicate polysomy 17
54. Analytical Validation of a Novel 6-Gene Signature for Prediction of Distant Recurrence in Estrogen Receptor-Positive, HER2-Negative, Early-Stage Breast Cancer.
55. Heterogeneity in Signaling Pathway Activity within Primary and between Primary and Metastatic Breast Cancer
56. Lessons Learned from Setting Up a Prospective, Longitudinal, Multicenter Study with Women at High Risk for Breast Cancer
57. Methylation Profile of X-Chromosome-Related Genes in Male Breast Cancer
58. The Physiological MicroRNA Landscape in Nipple Aspirate Fluid: Differences and Similarities with Breast Tissue, Breast Milk, Plasma and Serum
59. Methylation Profile of X-Chromosome-Related Genes in Male Breast Cancer
60. Erratum to: Differences in cancer gene copy number alterations between Epstein-Barr virus-positive and Epstein-Barr virus-negative nasopharyngeal carcinoma (Head & Neck, (2018), 40, 9, (1986-1998), 10.1002/hed.25195)
61. Application of Nipple Aspirate Fluid miRNA Profiles for Early Breast Cancer Detection and Management
62. The Physiological MicroRNA Landscape in Nipple Aspirate Fluid: Differences and Similarities with Breast Tissue, Breast Milk, Plasma and Serum
63. Amplification Testing in Breast Cancer by Multiplex Ligation-Dependent Probe Amplification of Microdissected Tissue
64. Prognostic Value of Estrogen Receptor α and Progesterone Receptor Conversion in Distant Breast Cancer Metastases
65. HER2 testing recommendations in the UK: dual- or single-colour in-situ hybridisation?
66. Formaldehyde substitute fixatives: effects on nucleic acid preservation
67. Frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer
68. Re: How Do You Tell Whether a Breast Cancer is HER2 Positive? Ongoing Studies Keep Debate in High Gear
69. Heterogeneity in signaling pathway activity within primary and between primary and metastatic breast cancer
70. Methylation Profile of X-Chromosome–Related Genes in Male Breast Cancer
71. The Physiological microRNA Landscape in Nipple Aspirate Fluid: Differences and Similarities with Breast Tissue, Breast Milk, Plasma and Serum
72. Promoter hypermethylation in ductal carcinoma in situ of the male breast
73. The molecular genetic make-up of male breast cancer
74. Frequent discordance in PD-1 and PD-L1 expression between primary breast tumors and their matched distant metastases
75. Frequent discordance in PD-1 and PD-L1 expression between primary breast tumors and their matched distant metastases
76. Promoter hypermethylation in ductal carcinoma in situ of the male breast
77. Application of Nipple Aspirate Fluid miRNA Profiles for Early Breast Cancer Detection and Management
78. The molecular genetic make-up of male breast cancer
79. The molecular genetic make-up of male breast cancer
80. Promoter hypermethylation in ductal carcinoma in situ of the male breast
81. Frequent discordance in PD-1 and PD-L1 expression between primary breast tumors and their matched distant metastases
82. Male breast cancer
83. HER-2/neu amplification testing in breast cancer by Multiplex Ligation-dependent Probe Amplification: influence of manual- and laser microdissection
84. Characterizing steroid hormone receptor chromatin binding landscapes in male and female breast cancer
85. Response to A. Matikas et al
86. Receptor conversion in distant breast cancer metastases : A Systematic Review and Meta-analysis
87. Differences in cancer gene copy number alterations between Epstein-Barr virus-positive and Epstein-Barr virus-negative nasopharyngeal carcinoma
88. Mutation profiling of key cancer genes in primary breast cancers and their distant metastases
89. Copy number changes at 8p11-12 predict adverse clinical outcome and chemo- and radiotherapy response in breast cancer
90. Methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA)
91. Copy number profiling of oncogenes in ductal carcinoma in situ of the male breast
92. Characterizing steroid hormone receptor chromatin binding landscapes in male and female breast cancer
93. Response to A. Matikas et al
94. PD-1 and PD-L1 Expression in Male Breast Cancer in Comparison with Female Breast Cancer
95. Role of columnar cell lesions in breast carcinogenesis: analysis of chromosome 16 copy number changes by multiplex ligation-dependent probe amplification
96. Receptor conversion in distant breast cancer metastases: A Systematic Review and Meta-analysis
97. Differences in cancer gene copy number alterations between Epstein-Barr virus-positive and Epstein-Barr virus-negative nasopharyngeal carcinoma
98. Copy number profiling of oncogenes in ductal carcinoma in situ of the male breast
99. Mutation profiling of key cancer genes in primary breast cancers and their distant metastases
100. Characterizing steroid hormone receptor chromatin binding landscapes in male and female breast cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.